CAR T-cell Therapy in Multiple Myeloma: Finding Its Right Place - Episode 5
Bridging to CAR T in R/R MM: Best Practices
Experts discuss their optimal strategy for bridging therapy when preparing patients to receive chimeric antigen receptor (CAR) T-cell therapy. They focus on selecting therapies that maintain disease control while awaiting CAR T infusion.
Video Player is loading.
Video content above is prompted by the following:
- In preparing patients to receive CAR T, what is your optimal strategy for bridging therapy?
Related Content:
